Th17 lineage commitment and HIV-1 pathogenesis

Current Opinion in HIV and AIDS

Volumn 5, Issue 2, 2010, Pages 158-165

  Ancuta, Petronela ^a,b,c   Monteiro, Patricia ^a,b,c   Sekaly, Rafick Pierre ^a,b,c,d  

^a Saint Luc Hospital   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c INSERM Unit 743   (Canada)

^d VGTI Florida   (United States)

Author keywords

CCR6; HIV; Human Th17; Microbiota; Mucosal immunity

Indexed keywords

CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; LYMPHOCYTE SURFACE MARKER; STAT3 PROTEIN;

ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CANDIDA ALBICANS; CELL LINEAGE; CELL SPECIFICITY; COMMENSALISM; DISEASE COURSE; FUNCTIONAL GENOMICS; GENE EXPRESSION REGULATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; GENOME IMPRINTING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNITY; IMMUNOLOGY; IMMUNOPATHOGENESIS; INTESTINE; LYMPHOCYTE DEPLETION; LYMPHOCYTE DIFFERENTIATION; MICROBIAL ACTIVITY; MICROFLORA; MOLECULAR MECHANICS; MUCOSA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; TISSUE SPECIFICITY;

BACTERIA; BACTERIAL TRANSLOCATION; FUNGI; HIV INFECTIONS; HIV-1; HUMANS; INTESTINAL MUCOSA; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 76949097773     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e3283364733     Document Type: Review

References (92)

1. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145-173.
2. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997; 18:263-266.
3. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787-793.
4. Glimcher LH, Murphy KM. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev 2000; 14:1693-1711.
5. Josefowicz SZ, Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity 2009; 30:616-625.
6. Li MO, Flavell RA. TGF-beta: a master of all T cell trades. Cell 2008; 134:392-404.
7. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/ T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007; 13:139-145.
8. McGeachy MJ, Cua DJ. Th17 cell differentiation: the long and winding road. Immunity 2008; 28:445-453.
9. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008; 453:1051-1057.
10. Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008; 8:337-348.
11. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009; 27:485-517.
12. Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009; 30:646-655.
13. Harrington LE, Hatton RD, Mangan PR, et al.. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6:1123-1132.
14. Park H, Li Z, Yang XO, et al.. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6:1133-1141.
15. Annunziato F, Romagnani S. Do studies in humans better depict Th17 cells? Blood 2009; 114:2213-2219.
16. Brenchley JM, Douek DC. HIV infection and the gastrointestinal immune system. Mucosal Immunol 2008; 1:23-30.
17. Brenchley JM, Paiardini M, Knox KS, et al.. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008; 112:2826-2835.
18. Raffatellu M, Santos RL, Verhoeven DE, et al.. Simian immunodeficiency virusinduced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 2008; 14:421-428.
19. Macal M, Sankaran S, Chun TW, et al.. Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses. Mucosal Immunol 2008; 1:475-488.
20. Cecchinato V, Trindade CJ, Laurence A, et al.. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol 2008; 1:279-288.
21. Favre D, Lederer S, Kanwar B, et al.. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog 2009; 5:e1000295.
22. Gosselin A, Monteiro P, Chomont N, et al.. Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+ CD4+ T-cells are highly permissive to HIV-1 infection. J Immunol 2009 (in press).
23. Yao Z, Fanslow WC, Seldin MF, et al.. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 1995; 3:811-821
24. Oppmann B, Lesley R, Blom B, et al.. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13:715-725.
25. Cua DJ, Sherlock J, Chen Y, et al.. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421:744-748.
26. Yen D, Cheung J, Scheerens H, et al.. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006; 116:1310-1316.
27. Gerosa F, Baldani-Guerra B, Lyakh LA, et al.. Differential regulation of interleukin and interleukin 23 production in human dendritic cells. J Exp Med 2008; 205:1447-1461.
28. Acosta-Rodriguez EV, Rivino L, Geginat J, et al.. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007; 8:639-646.
29. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8:942-949.
30. Wilson NJ, Boniface K, Chan JR, et al.. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007; 8:950-957.
31. Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008; 9:641-649.
32. or interleukin-23 in serum-free conditions were necessary and sufficient to induce interleukin-17 expression in naive human CD4+ T cells from cord blood.
33. Weaver CT, Harrington LE, Mangan PR, et al.. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006; 24:677-688.
34. Denning TL, Wang YC, Patel SR, et al.. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol 2007; 8:1086-1094.
35. Mucida D, Park Y, Kim G, et al.. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317:256-260.
36. Chaudhry A, Rudra D, Treuting P, et al.. CD4+Regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009; 326:986-991.
37. Yang XO, Pappu BP, Nurieva R, et al.. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008; 28:29-39.
38. Chen Z, Laurence A, O'Shea JJ. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin Immunol 2007; 19:400-408.
39. Brustle A, Heink S, Huber M, et al.. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol 2007; 8:958-966.
40. Veldhoen M, Hirota K, Westendorf AM, et al.. The aryl hydrocarbon receptor links T(H)17-cell-mediated autoimmunity to environmental toxins. Nature 2008; 453:106-109.
41. Veldhoen M, Hirota K, Christensen J, et al.. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J Exp Med 2009; 206:43-49.
42. Schraml BU, Hildner K, Ise W, et al.. The AP-1 transcription factor Batf controls T(H)17 differentiation. Nature 2009; 460:405-409.
43. Zhou L, Littman DR. Transcriptional regulatory networks in Th17 cell differentiation. Curr Opin Immunol 2009; 21:146-152.
44. Trifari S, Kaplan CD, Tran EH, et al.. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 2009; 10:864-871.
45. Mangan PR, Harrington LE, O'Quinn DB, et al.. Transforming growth factorbeta induces development of the T(H)17 lineage. Nature 2006; 441:231-234.
46. Veldhoen M, Hocking RJ, Atkins CJ, et al.. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24:179-189.
47. Bettelli E, Carrier Y, Gao W, et al.. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235-238.
48. Van De Veerdonk FL, Marijnissen RJ, Kullberg BJ, et al.. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 2009; 5:329-340.
49. Milner JD, Brenchley JM, Laurence A, et al.. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008; 452:773-776.
50. De Beaucoudrey L, Puel A, Filipe-Santos O, et al.. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 2008; 205:1543-1550.
51. Wilson CB, Rowell E, Sekimata M. Epigenetic control of T-helper-cell differentiation. Nat Rev Immunol 2009; 9:91-105.
52. Wei G, Wei L, Zhu J, et al.. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009; 30:155-167.
53. Yang D, Chertov O, Bykovskaia SN, et al.. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999; 286:525-528.
54. Annunziato F, Cosmi L, Santarlasci V, et al.. Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204:1849-1861.
55. Cosmi L, De Palma R, Santarlasci V, et al.. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med 2008; 205:1903-1916.
56. Kleinschek MA, Boniface K, Sadekova S, et al.. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med 2009; 206:525-534.
57. Gill SR, Pop M, Deboy RT, et al.. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312:1355-1359.
58. Mazmanian SK. Gut immune balance is as easy as S-F-B. Immunity 2009; 31:536-538.
59. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453:620-625.
60. Sokol H, Pigneur B, Watterlot L, et al.. Faecalibacterium prausnitzii is an antiinflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008; 105:16731-16736.
61. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005; 122:107-118.
62. Ivanov II, Frutos Rde L, Manel N, et al.. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008; 4:337-349.
63. Atarashi K, Nishimura J, Shima T, et al.. ATP drives lamina propria T(H)17 cell differentiation. Nature 2008; 455:808-812.
64. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9:313-323.
65. Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, et al.. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009; 31:677-689.
66. Ivanov II, Atarashi K, Manel N, et al.. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139:485-498.
67. Aujla SJ, Dubin PJ, Kolls JK. Th17 cells and mucosal host defense. Semin Immunol 2007; 19:377-382.
68. Dubin PJ, Kolls JK. Th17 cytokines and mucosal immunity. Immunol Rev 2008; 226:160-171.
69. Wenner M. A cultured response to HIV. Nat Med 2009; 15:594-597.
70. Yue FY, Merchant A, Kovacs CM, et al.. Virus specific IL-17 producing CD4+ T cells are detectable in early HIV-1 infection. J Virol 2008; 82:6767-6771.
71. Kebir H, Kreymborg K, Ifergan I, et al.. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007; 13:1173-1175.
72. Kotler DP. Characterization of intestinal disease associated with human immunodeficiency virus infection and response to antiretroviral therapy. J Infect Dis 1999; 179 (Suppl 3):S454-S456.
73. Brenchley JM, Schacker TW, Ruff LE, et al.. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-759.
74. Brenchley JM, Price DA, Douek DC. HIV disease: fallout from a mucosal catastrophe? Nat Immunol 2006; 7:235-239.
75. Brenchley JM, Price DA, Schacker TW, et al.. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-1371.
76. Clerici M, Shearer GM. A TH1->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14:107-111.
77. Duerr RH, Taylor KD, Brant SR, et al.. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314:1461-1463.
78. Ancuta P, Kamat A, Kunstman KJ, et al.. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE 2008; 3:e2516.
79. Berlin C, Berg EL, Briskin MJ, et al.. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993; 74:185-1185.
80. Wang C, Kang SG, Lee J, et al.. The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol 2009; 2:173-183.
81. Sallusto F, Mackay CR. Chemoattractants and their receptors in homeostasis and inflammation. Curr Opin Immunol 2004; 16:724-731.
82. Reboldi A, Coisne C, Baumjohann D, et al.. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 2009; 10:514-523.
83. Li Q, Estes JD, Schlievert PM, et al.. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009; 458:1034-1038.
84. Herbein G, Khan KA. Is HIV infection a TNF receptor signalling-driven disease? Trends Immunol 2008; 29:61-67.
85. Misse D, Yssel H, Trabattoni D, et al.. IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction. J Immunol 2007; 178:407-415.
86. Duhen T, Geiger R, Jarrossay D, et al.. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009; 10:857-863.
87. Kunkel EJ, Butcher EC. Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002; 16:1-4.
88. Guess JC, McCance DJ. Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production. J Virol 2005; 79:14852-14862.
89. Le Borgne M, Etchart N, Goubier A, et al.. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 2006; 24:191-201.
90. Lee JW, Wang P, Kattah MG, et al.. Differential regulation of chemokines by IL-17 in colonic epithelial cells. J Immunol 2008; 181:6536-6545.
91. Backhed F, Ley RE, Sonnenburg JL, et al.. Host-bacterial mutualism in the human intestine. Science 2005; 307:1915-1920.
92. Slack E, Hapfelmeier S, Stecher B, et al.. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 2009; 325:617-620.